Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-12

Clinical Trial Update: Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African Americans [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial sponsored by Vanderbilt University Medical Center is investigating whether enhancing parasympathetic activity can improve endothelial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Endothelial Dysfunction | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING